Google Ventures-Backed Arcus Biosciences Scoops Up $107M in Series C
Arcus Biosciences has now closed a $107 million Series C round for its mission to provide...
Scientists Design CRISPR edited, Self-Destructible Transgenic Mosquitoes
Yellow, Three-Eyed, Wingless Mosquitoes Created Using CRISPR Gene Editing Tool with the Cas9 enzyme embedded in their germline.
The...
Partners HealthCare Raises $171M for Venture Fund
Boston-based hospital system Partners Healthcare has closed $171.1 million to add to its venture funds with plans to...
Celgene’s Michael Pehl Appointed as New CEO of Immunomedics
Immunomedics has now announced that former Celgene president Michael Pehl will take over as president and chief executive officer effective Dec. 7,...
Chemical Responsible for Ripening also dictates Plant’s Circadian Rhythm
There’s a ticking clock that your whole life is based on/around and it isn’t your alarm...
Researchers found The Protein that “Rules” our Hearts: Titin
The contractile machinery of heart and skeletal muscles has as an essential component the Thick filament,...
Meteorite Metal that obliterated Dinosaurs Could Help Us Send Cancer
Sixty-five million years ago, the last of the non-avian dinosaurs went extinct. So too did...
Janssen Inks Potential $1.5bn Deal with Zymeworks
Zymeworks has now licensed Janssen Biotech Inc. global rights to use its Azymetric and EFECT (Effector Function Enhancement and Control Technology) platforms in the research,...
Novartis collaborates with Homology to Adapt Genome Editing Technology
Pharma giant, Novartis, has now announced a collaboration with start-up, Homology Medicines to expand its programs...
New Molecules Capable Of Destroying Resistance to Antibiotics
Superbugs cultivated in a laboratory.
Superbugs are strains of bacteria resistant to several types of antibiotics. Their main...
Grand Challenges India - Fourth Call - Immunization Data: Innovating for Action (IDIA)
Grand Challenges India is proud to announce its fourth call ‘Immunization Data:...
BioTherapeutics licenses New CRISPR-Cas Gene Editing Technology
Excision BioTherapeutics, a company focused on the development and commercialization of advanced gene editing therapeutics for the...
Myriad Genetics is with Department of VA to Trial MDD Genetic Test
Assurex Health, a wholly-owned subsidiary of Myriad Genetics, has now announced that it...
Leverhulme Trust Early Career Fellowships
This call expires in :
Early Career Fellowships:
Offering 50% match-funding for the salary costs of three-year academic research position, the scheme...
